BioSpace News Archive

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it will receive a milestone payment from Roche triggered by European Commission conditional marketing authorisation for Polivy® (polatuzumab vedotin).

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI) disorders and diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s resubmission of its 505(b)(2) New Drug Application (NDA) for Gimoti™

Plan Management Corp. (PMC), the long-time leader in the equity benefit plan and cap table management software field, announced today that the latest OptionTrax® software release introduces two major enhancements that make life significantly easier for equity plan and securities administrators.

Bio-Techne, Fresenius Kabi, and Wilson Wolf have formed a new joint venture company to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy.

CV Sciences, Inc, a preeminent supplier and manufacturer of hemp cannabidiol products through its brand PlusCBD Oil™, is the first-ever CBD sponsor of the Farmers Insurance Open.

Rite Aid Corporation announced the early results of its previously announced offer to exchange up to $600 million aggregate principal amount of its outstanding 6.125% Senior Notes due 2023 for newly issued 7.500% Senior Secured Notes due 2025, upon the terms and subject to the conditions set forth in the offering memorandum dated January 6, 2020.

LSNE Contract Manufacturing (LSNE), a privately held contract development and manufacturing organization, is pleased to announce a successful Pre-Approval Inspection (PAI) performed by the US Food and Drug Administration (FDA) at its aseptic fill finish facility in León, Spain.

Cerus Corporation (Nasdaq:CERS) is pleased to announce the recent publication of the 16th Annual Hemovigilance report by the French National Agency for Medicines and Health Products (ANSM) which oversees the safety of medicine and other health products.

Northpoint Recovery, which operates inpatient and outpatient addiction treatment facilities in Washington and Idaho, has named Brian Smart, MD as Washington Medical Director.

Pendulum Therapeutics, an evidence-based microbiome company, announced today the formation of its Scientific Advisory Board (SAB) and Medical Advisory Board (MAB).